- Home
- TLSI vs TDF Comparison
TLSI vs TDF Comparison
Compare TLSI & TDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- TDF
- Stock Information
- Founded
- TLSI 2010
- TDF 1994
- Country
- TLSI United States
- TDF Singapore
- Employees
- TLSI N/A
- TDF N/A
- Industry
- TLSI Medical Specialities
- TDF Finance/Investors Services
- Sector
- TLSI Health Care
- TDF Finance
- Exchange
- TLSI Nasdaq
- TDF Nasdaq
- Market Cap
- TLSI 244.3M
- TDF 244.7M
- IPO Year
- TLSI N/A
- TDF N/A
- Fundamental
- Price
- TLSI $4.73
- TDF $11.76
- Analyst Decision
- TLSI Strong Buy
- TDF
- Analyst Count
- TLSI 4
- TDF 0
- Target Price
- TLSI $11.13
- TDF N/A
- AVG Volume (30 Days)
- TLSI 118.6K
- TDF 79.2K
- Earning Date
- TLSI 11-13-2025
- TDF 01-01-0001
- Dividend Yield
- TLSI N/A
- TDF N/A
- EPS Growth
- TLSI N/A
- TDF N/A
- EPS
- TLSI N/A
- TDF N/A
- Revenue
- TLSI $35,990,000.00
- TDF N/A
- Revenue This Year
- TLSI $56.79
- TDF N/A
- Revenue Next Year
- TLSI $54.15
- TDF N/A
- P/E Ratio
- TLSI N/A
- TDF N/A
- Revenue Growth
- TLSI 45.50
- TDF N/A
- 52 Week Low
- TLSI $3.42
- TDF $7.15
- 52 Week High
- TLSI $5.88
- TDF $10.62
- Technical
- Relative Strength Index (RSI)
- TLSI 48.36
- TDF 60.24
- Support Level
- TLSI $4.42
- TDF $11.30
- Resistance Level
- TLSI $4.67
- TDF $12.04
- Average True Range (ATR)
- TLSI 0.23
- TDF 0.24
- MACD
- TLSI -0.03
- TDF -0.00
- Stochastic Oscillator
- TLSI 61.87
- TDF 61.33
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About TDF Templeton Dragon Fund Inc.
Templeton Dragon Fund Inc is a closed-end management investment company. The fund seeks long-term capital appreciation by investing majority of its total assets in equity securities of China companies. It invests in various sectors such as gas & consumable fuels, auto components, banks, beverages, communications equipment, healthcare equipment & supplies, restaurants & leisure, household durables and many others.